Icon
+91 94997 68112
Login Register

Nexium 24HR OTC - (EQ 20MG BASE; Tablet, Delayed Release OTC)

Esomeprazole Astrazeneca
EQ 20MG BASE; Tablet, Delayed Release OTC
Less Than $1000 mn
Less Than 5
More Than 5
More Than 5
 None
Less Than 5
Less Than 5
over the counter drug approved for the treatment of frequent heartburn (2 or more days a week).
Yes
******* *** ***** **** ** ** *** *** *** ****** *** **** ******* '*** (*** **, ****), '*** (*** **, ****). ** ****** **** **** *** ********* ****** ** ***** ****. ****, ** *****'*, ********* *** ****** ***** **** ** ** *** **** ******* *** **** ************ *********. ******* ***** **** ***** **** ** **** *** **** ******* *** *** ************ *********. *** ******** ****** ** ************ ** ******* *******. ** *****'* ******** *** ******* ** *** ****. **, ** ******** **** ******** **** ****** *** ******* **** ********.
Nexium 24HR OTC Patent 1 Patent 2 Patent 3
******* ******* ******* *******
***** ******* ******* *******
** *****'* *** ** ** **** ** *** **, **** **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** *, **** ******* **** ****** **** ********
***** *** \ ** *** *, **** ******* **** ****** **** ********
** *****'* ** \ ** *** **, **** *** ** ** ******** ******** ** *** **, ****
  1. *** *, **** : ******* *** ***** ******** *********** ***** *** **** ** *** ****** *** **** ******* '*** (*** **, ****), '*** (*** **, ****)
  2. *** *, **** : *********** ***** ******** ***** ******* ******* *** ***** ** ******** ***** ** **.
  3. *** **, **** : ********** ********* **** *******
  4. *** **, **** : *********** ***** * **** ******* ** *****'* ** ** *****'* ***** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****).
  5. *** **, **** : *********** ***** * **** ******* ****** ** ****** ***** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****).
  6. *** **, **** : *********** ***** * **** ******* ********* ** ********* ***** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****).
  7. *** **, **** : *********** ***** * **** ******* ********* ** ******* '*** *** '***
  8. *** **, **** : ********** ********* **** *****
  9. *** **, **** : *********** ***** * **** ******* ***** ** ***** ***** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****).
  10. *** *, **** : ********** ********* **** ******
  11. *** **, **** : ********** ********* **** *********
  12. *** **, **** : *********** ******* **** *********. ***** *** ***** ** ********** *** *** *****.
  13. *** **, **** : ********** ********* **** *****
  14. *** **, **** : *** ***** * *********** ********* ******* *********** ******* * *********** ** ***-************ ** ****** ****** ****** **. *,***,***
  15. *** **, **** : ***** ***** **** '*** ****** ** *** ******** ** ** *****'*
  16. *** **, **** : ***** ***** * ******** *** *********** ******** ** ***-************ *** ********** ** ****** '*** ******* *********** ***************
  17. *** **, **** : ********** ********* **** ***** ** ****** '***, ***** *** ***** ** ********** *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.